U.S.–Russia Peace Talks Stall as Kremlin Rejects Key Proposals 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
Federal Judge Blocks Trump Administration’s Medicaid Funding Restrictions Targeting Planned Parenthood 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Taiwan Signals Openness to Renew Ties with Honduras as Election Unfolds 
Drones Spotted Near Zelenskiy’s Flight Path in Ireland Trigger Security Alert 
U.S. Soybean Shipments to China Gain Momentum as Trade Tensions Ease 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Australia Progresses AUKUS Review as U.S. Affirms Strong Support 
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
U.S. Defense Chief Pete Hegseth Defends Controversial Second Strike on Suspected Drug-Smuggling Vessel 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.
